PB2128: CLINICAL CONSENSUS ON FIRST-LINE (1L) TREATMENTS FOR TRANSPLANT-INELIGIBLE (TIE) PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): DELPHI PANEL OF US HEMATOLOGISTS AND ONCOLOGISTS
HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e8448894
10.1097/01.hs9.0000975276.84488.94